表紙
市場調査レポート

細胞増殖の技術と世界市場

Cell Expansion Technologies and Global Markets

発行 BCC Research 商品コード 340661
出版日 ページ情報 英文 161 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
細胞増殖の技術と世界市場 Cell Expansion Technologies and Global Markets
出版日: 2015年09月28日 ページ情報: 英文 161 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

細胞増殖関連の市場は、動物の細胞とヒトの細胞の2つに大別することができます。細胞増殖に用いられる動物の細胞には、胚性幹細胞や間充織幹細胞 (MSC) などがさまざまなものがあり、ヒトの細胞は、幹細胞と分化細胞に分かれます。これらの細胞は、診断、創薬と開発、再生医療などの用途で使用され、病院や診断センター、研究機関、大学、生物医薬品メーカーやバイオテクノロジー企業がエンドユーザーになります。細胞増殖関連市場は、消耗品、器具、細胞増殖支援機器の3分野に大別することができ、消耗品には、試薬、培地、漿液、各種使い捨て製品が、器具には、自動細胞増殖システムやバイオリアクターなどが、細胞増殖支援機器には、遠心分離機、フローサイトメーター、ろ過システム、顕微鏡、培養器、層流キャビネットなどが含まれます。

当レポートは、世界の細胞増殖関連市場にスポットライトを当て、細胞タイプ別、製品別、用途別、エンドユーザー別、地域別に分析したもので、特許や競合状況に関する分析に加え、主要企業のプロファイルも網羅します。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 細胞増殖関連市場の概要

  • 市場の定義と範囲
  • 幹細胞技術と細胞増殖
    • 用途
    • 細胞増殖
    • 幹細胞の大規模増殖
    • 骨髄由来幹細胞の増殖
    • G-REX技術
    • 臓器再生への応用
    • ナノテクノロジー
  • バリューチェーン分析
  • 臨床試験
  • 各国政府の規制と償還制度
    • 北米
    • 欧州
    • アジア太平洋
    • 償還のシナリオ
    • 提携
  • 市場の力学
    • 成長促進要因
    • 阻害要因
    • ビジネスチャンス

第4章 世界の細胞増殖関連市場−細胞タイプ別

  • 動物の細胞
    • 単層系
    • ニューロスフィア系
    • 地域別の市場規模と予測
    • ヒトの細胞
    • タイプ別の市場規模と予測
    • 地域別の市場規模と予測
    • 幹細胞
    • 分化細胞

第5章 世界の細胞増殖関連市場−製品別

  • 製品タイプ別の市場規模と予測
  • 消耗品
    • タイプ別の市場規模と予測
    • 地域別の市場規模と予測
    • 試薬、培地、漿液
    • 使い捨て製品
  • 器具
    • タイプ別の市場規模と予測
    • 地域別の市場規模と予測
    • 自動細胞増殖システム
    • バイオリアクター
  • 支援機器
    • タイプ別の市場規模と予測
    • 地域別の市場規模と予測
    • 遠心分離機
    • フローサイトメーター
    • ろ過システム
    • 顕微鏡
    • 培養器
    • 層流キャビネット
    • その他の支援機器

第6章 世界の細胞増殖関連市場−用途別

  • 臨床診断
    • 毒素性ショック症候群の臨床診断
    • HIVの臨床診断
    • ニューロスフィア (幹細胞としての形質を有する) アッセイ
    • 地域別の市場規模と予測
  • 創薬と開発
    • 地域別の市場規模と予測
  • 再生医療と幹細胞研究
    • 組織工学と臓器移植
    • 皮膚科関連の用途
    • 心血管関連の用途
    • 中枢神経系 (CNS) 関連の用途
    • 整形外科関連の用途
    • 歯科関連の用途
    • 幹細胞研究
    • 地域別の市場規模と予測
  • 他の用途
    • 疾病機序の研究
    • 個別化医療
    • 自己免疫疾患
    • 筋肉再生
    • 眼疾患
    • 臓器再生
    • 地域別の市場規模と予測

第7章 世界の細胞増殖関連市場−エンドユーザー別

  • エンドユーザー別の市場規模と予測
  • 病院と診断センター
    • 地域別の市場規模と予測
  • 研究機関と学術機関
    • 研究機関で行われている研究の主な領域
    • 地域別の市場規模と予測
  • 生物医薬品とバイオテクノロジー関連の企業
    • 生物医薬品企業
    • バイオテクノロジー企業
    • 地域別の市場規模と予測

第8章 世界の細胞増殖関連市場−地域別

  • 北米
    • 用途別の市場規模と予測
  • 欧州
    • 用途別の市場規模と予測
  • アジア太平洋
    • 用途別の市場規模と予測
  • 他の地域
    • 用途別の市場規模と予測

第9章 特許分析

  • 各社が保有する米国特許の分析
  • 各社が保有する欧州特許の分析
  • 各社が保有する日本特許の分析

第10章 競合状況

  • 新製品投入
  • 合意
  • 承認

第11章 主要企業各社のプロファイル

  • BECTON, DICKINSON AND COMPANY
  • CELLPROTHERA
  • CORNING INC.
  • CYTOMATRIX
  • DANAHER CORP.
  • GE HEALTHCARE
  • LIFE TECHNOLOGIES LTD.
  • MERCK MILLIPORE
  • MILTENYI BIOTEC
  • NEXIMMUNE INC.
  • PLURISTEM THERAPEUTICS INC.
  • RENEURON GROUP PLC
  • REPLICEL LIFE SCIENCES INC.
  • SIGMA-ALDRICH CORP.
  • STEMCELL TECHNOLOGIES INC.
  • TC BIOPHARM LTD.
  • TERUMO BCT
  • THERMO FISHER SCIENTIFIC INC.
  • VORNIA BIOMATERIALS LTD.

第12章 付録

図表リスト

目次
Product Code: BIO144A

REPORT HIGHLIGHTS

The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.

This report provides:

  • An overview of the global markets for cell expansion, mainly categorized into two major types, animal cells and human cells.
  • Analyses of global market trends, with data for 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Geographical breakdown across: North America, Europe, Asia-Pacific and ROW.
  • Analysis of applications including clinical diagnostics, drug discovery and development, regenerative medicine and others.
  • Coverage of automated cell expansion systems, bioreactors, and cell expansion supporting equipment.
  • Coverage of consumables including reagents, media, & sera and disposables.
  • Profiles of major players in the industry.

SCOPE OF THE REPORT

On the basis of cell type, the cell expansion market is divided into two major types: animal cells and human cells. Animal cell expansion in this report includes various cells such as embryonic stem cells and mesenchymal stem cells (MSC). Furthermore, the human cells used in cell expansion are classified as stem cells and differentiated cells. These cell types are used in applications such as diagnostics, drug discovery and development, regenerative medicine and others. The end users of this market are hospitals and diagnostic centers, research institutes and academics, and bio-pharmaceutical and biotechnology companies. Cell expansion applications are analyzed in detail in the report with their potential scope and opportunities throughout the forecast period.

The global cell expansion product market is segmented into three major categories: consumables, instruments and cell expansion supporting equipment. The consumables category consists of reagents, media, and sera and disposables. The instrument category is comprised of automated cell expansion systems and bioreactors. The cell expansion supporting equipment category is comprised of centrifuges, flow cytometers, filtration systems, microscopes, incubators, laminar air flow cabinets and other equipment.

By geography, the market segments are North America, Europe, Asia-Pacific and ROW. Companies profiled in this report are Becton, Dickinson and Company; GE Healthcare; Thermo Fisher Scientific Inc.; Corning Inc.; Danaher Corp.; Merck Millipore; Terumo BCT; STEMCELL Technologies; Sigma-Aldrich Corp.; Miltenyi Biotec; Life Technologies; Replicell; Neximmune; TC Biopharm; Pluristem Therapeutics; ReNeuron; Voria Biomaterials; CellProthera; and Cytomatrix.

ANALYST'S CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the health care domain with respect to medical devices, in the life sciences market and in the chemical domain. She has frequently provided research services that include strategic recommendations and top business strategies to assist market players in decision-making. Ms. Jeevane holds a Bachelor of Science in biotechnology and an MBA in marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASON FOR DOING STUDY
  • SCOPE OF THE REPORT
  • METHODOLOGY AND INFORMATION SOURCES
  • INTENDED AUDIENCE
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL CELL EXPANSION MARKET BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - CELL EXPANSION MARKET OVERVIEW

  • MARKET DEFINITION AND SCOPE
  • STEM CELL TECHNOLOGIES AND CELL EXPANSION
    • APPLICATIONS
    • CELL EXPANSION
      • Trends in Cell Expansion
        • Cryopreservation and Cell Banking
          • Cryopreservation
            • TABLE 1: GUIDELINES ADOPTED FOR SUCCESSFUL CRYOPRESERVATION DURING CELL EXPANSION OPERATIONS
          • Cell Banking
    • LARGE-SCALE EXPANSION OF STEM CELLS
    • BONE MARROW-DERIVED STEM CELL EXPANSION
    • G-REX TECHNOLOGY
    • APPLICATIONS IN ORGAN REGENERATION
    • NANOTECHNOLOGY
      • Nanoparticles
      • Nanoscaffolds
  • VALUE CHAIN ANALYSIS
    • FIGURE 1: VALUE CHAIN ANALYSIS FOR CELL EXPANSION MARKET
    • PRIMARY ACTIVITIES
    • SECONDARY ACTIVITIES
  • CLINICAL TRIALS
    • CLINICAL TRIALS COMPLETED
      • TABLE 2: CLINICAL TRIALS OF CELL EXPANSION RESEARCH (COMPLETED)
    • CLINICAL TRIALS TERMINATED
      • TABLE 3: CLINICAL TRIALS OF CELL EXPANSION RESEARCH (TERMINATED)
    • OTHER CLINICAL TRIALS
      • TABLE 4: OTHER CLINICAL TRIALS OF CELL EXPANSION RESEARCH
    • CLINICAL TRIALS CONDUCTED IN REGENERATIVE MEDICINE
      • TABLE 5: CLINICAL TRIAL FOR INITIAL EVALUATION OF CELADERM ACTIVITY (COMPLETED)
      • TABLE 6: CLINICAL TRIAL FOR REGENERATIVE MEDICINE IN OCULAR SURFACE (COMPLETED)
      • TABLE 7: CLINICAL TRIAL FOR THE EFFECTS OF INTRA-ARTICULAR INJECTION OF PLATELET-RICH PLASMA
  • GOVERNMENT REGULATIONS AND REIMBURSEMENT
    • REGULATIONS IN NORTH AMERICA
    • REGULATIONS IN EUROPE
    • REGULATIONS IN ASIA-PACIFIC
      • India
      • China
      • Japan
      • Australia
        • TABLE 8: CLONING SCENARIO IN ASIA-PACIFIC
    • REIMBURSEMENT SCENARIO
    • THE ALLIANCE
  • MARKET DYNAMICS
    • DRIVERS
      • Technological Advancements in Cell Expansion
      • Increasing Incidence of Chronic Disease
      • Rising Number of GMP-Certified Cell Therapy Facilities
      • Potential of Nanotechnology
      • Expiry of Drug Patents
      • New Applications
      • Advancements in Stem Cell Technology
    • RESTRAINTS
      • Stringent Regulatory Impositions on Cellular Therapy Products
      • High Costs of Cell Therapy Products
      • Ethical Concerns Regarding the Research on Cell Biology
    • OPPORTUNITIES
      • Rising Innovations in Cell Expansion: 3D Cell-Expansion Technology
      • Growth Prospects in Emerging Countries
      • Future Growth Opportunities: Regenerative Medicine

CHAPTER 4 - GLOBAL CELL EXPANSION MARKET BY CELL TYPE

  • TABLE 9: GLOBAL CELL EXPANSION MARKET BY CELL TYPE, THROUGH 2020 ($ MILLIONS)
  • ANIMAL CELLS
    • MONOLAYER SYSTEM
    • NEUROSPHERE SYSTEMS
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 10: GLOBAL ANIMAL CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • HUMAN CELLS
      • TABLE 11: COMMONLY USED MATERIALS IN HUMAN CELL EXPANSION EXPERIMENTS BY COMPANY
    • MARKET SIZE AND FORECAST BY TYPE
      • TABLE 12: GLOBAL HUMAN CELL EXPANSION MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 13: GLOBAL HUMAN CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • STEM CELLS
      • Human Embryonic Stem Cell Expansion
      • Human Hematopoietic Stem Cell Expansion
      • Market Size and Forecast by Region
        • TABLE 14: GLOBAL HUMAN STEM CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • DIFFERENTIATED CELLS
      • Clonal Expansion Theory
      • Human T-cell Expansion
      • Market Size and Forecast by Region
        • TABLE 15: GLOBAL HUMAN DIFFERENTIATED CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 5 - GLOBAL CELL EXPANSION MARKET BY PRODUCT

  • MARKET SIZE AND FORECAST BY PRODUCT TYPE
    • TABLE 16: GLOBAL CELL EXPANSION MARKET BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
  • CONSUMABLES
    • MARKET SIZE AND FORECAST BY TYPE
      • TABLE 17: GLOBAL CELL EXPANSION MARKET FOR CONSUMABLES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 18: GLOBAL CELL EXPANSION MARKET FOR COSUMABLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • REAGENTS, MEDIA AND SERA
      • Cortical Stem Cell Expansion Protocol for Monolayer Systems
      • Procedure for Cell Expansion Protocol
      • Cell-expansion Procedure for the Monolayer System
      • Cell-expansion Procedure for the Neurosphere System
        • TABLE 19: SOME COMMERCIALLY AVAILABLE REAGENTS, MEDIA AND SERA
      • Market Size and Forecast by Region
        • TABLE 20: GLOBAL REAGENTS, MEDIA AND SERA MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • DISPOSABLES
      • Market Size and Forecast by Type
        • TABLE 21: GLOBAL DISPOSABLES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
      • Market Size and Forecast by Region
        • TABLE 22: GLOBAL DISPOSABLES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Tissue Culture Flasks
        • Tissue Culture Flasks with Re-Closable Lids or Peel off Foils
          • TABLE 23: SOME COMMERCIALLY AVAILABLE TISSUE CULTURE FLASKS
      • Market Size and Forecast by Region
        • TABLE 24: GLOBAL CELL TISSUE CULTURE FLASKS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Bioreactor Accessories
        • Foam Disks
        • Flexible Adapter for the Exhaust Cooler
          • TABLE 25: COMMERCIALLY AVAILABLE UNIVESSEL BIOREACTORS BY HEIGHT (MM)
      • Balances for the Culture Vessels and Substrates
      • Turbidity (Cell Concentration) Measurements
      • Recirculation Coolers
      • Pre-Fabricated Bioreactor Accessory Kits
        • TABLE 26: COMMERCIALLY AVAILABLE BIOREACTOR ACCESSORIES
      • Market Size and Forecast by Region
        • TABLE 27: GLOBAL BIOREACTOR ACCESSORIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Other Disposables
        • Serological Pipettes
        • Cell Culture Dishes
        • Cell Culture Plates
        • Market Size and Forecast by Region
          • TABLE 28: GLOBAL OTHER DISPOSABLES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • INSTRUMENTS
    • MARKET SIZE AND FORECAST BY TYPE
      • TABLE 29: GLOBAL INSTRUMENTS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 30: GLOBAL INSTRUMENTS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • AUTOMATED CELL EXPANSION SYSTEMS
      • Improving Process Scalability
      • Working of Automated Cell Expansion Systems
        • TABLE 31: COMMERCIALLY AVAILABLE AUTOMATED CELL EXPANSION SYSTEMS
      • Market Size and Forecast by Region
        • TABLE 32: GLOBAL AUTOMATED CELL EXPANSION SYSTEMS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • BIOREACTORS
      • TABLE 33: SOME COMMERCIALLY AVAILABLE BIOREACTORS FOR CELL EXPANSION
      • Market Size and Forecast by Type
        • TABLE 34: GLOBAL BIOREACTORS INSTRUMENTS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
      • Market Size and Forecast by Region
        • TABLE 35: GLOBAL BIOREACTORS INSTRUMENTS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Micro Carrier Batch Culture Bioreactors
        • Market Size and Forecast by Type
          • TABLE 36: GLOBAL MICRO CARRIER BATCH CULTURE BIOREACTORS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
        • Market Size and Forecast by Region
          • TABLE 37: GLOBAL MICRO CARRIER BATCH CULTURE BIOREACTORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Micro Carrier-Based Anchorage-Dependant Batch Culture Bioreactors
        • Market Size and Forecast by Region
          • TABLE 38: GLOBAL MICRO CARRIER BASED ANCHORAGE-DEPENDENT BATCH CULTURE BIOREACTORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Suspension-based Anchorage-Independent Batch Culture Bioreactors
        • Market Size and Forecast by Region
          • TABLE 39: GLOBAL SUSPENSION-BASED ANCHORAGE-INDEPENDENT BATCH CULTURE BIOREACTOR MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • Hollow-fiber Perfusion Bioreactors
        • Features and Benefits
        • Applications
        • Market Size and Forecast by Region
          • TABLE 40: GLOBAL PERFUSION/HOLLOW FIBER BIOREACTOR MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUPPORTING EQUIPMENT
    • MARKET SIZE AND FORECAST BY TYPE
      • TABLE 41: GLOBAL SUPPORTING EQUIPMENT MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 42: GLOBAL SUPPORTING EQUIPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • CENTRIFUGES
      • Laboratory Separation
      • Isotope Separation
      • Human Centrifuges
      • Laboratory Centrifuges
        • TABLE 43: COMMERCIALLY AVAILABLE CENTRIFUGES FOR CELL EXPANSION
      • Market Size and Forecast by Region
        • TABLE 44: GLOBAL CENTRIFUGE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • FLOW CYTOMETERS
      • Applications
        • TABLE 45: COMMERCIALLY AVAILABLE FLOW CYTOMETERS FOR CELL EXPANSION
      • Market Size and Forecast by Region
        • TABLE 46: GLOBAL FLOW CYTOMETERS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • FILTRATION SYSTEMS
      • Vacuum Driven Sterile Filters
      • Sterile Syringe Filters
        • TABLE 47: COMMERCIALLY AVAILABLE FILTRATION SYSTEMS USED IN CELL EXPANSION EXPERIMENTS
      • Market Size and Forecast by Region
        • TABLE 48: GLOBAL FILTRATION SYSTEMS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • MICROSCOPES
      • Inverted Microscopy
      • Electron Microscopy
      • Light Microscopes
      • Live Cell Microscopy
        • TABLE 49: COMMERCIALLY AVAILABLE MICROSCOPES FOR CELL EXPANSION EXPERIMENTS
      • Market Size and Forecast by Region
        • TABLE 50: GLOBAL MICROSCOPES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • INCUBATORS
      • Orbital Shaking Incubators
        • TABLE 51: COMMERCIALLY AVAILABLE INCUBATORS FOR CELL EXPANSION EXPERIMENTS
      • Market Size and Forecast by Region
        • TABLE 52: GLOBAL INCUBATORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • LAMINAR AIR FLOW CABINETS
      • Uses
      • Types of Laminar Air Flow Cabinets
        • Horizontal Laminar Air Flow Cabinets
        • Vertical Laminar Flow Cabinets
          • Laminar Flow Benches and Booths
          • Laminar Flow Cabinets and Hoods
      • Market Size and Forecast by Region
        • TABLE 53: GLOBAL LAMINAR AIR FLOW CABINET MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • OTHER SUPPORTING EQUIPMENT
      • Water Baths
      • Falcon and Eppendorf Tubes
      • Market Size and Forecast by Region
        • TABLE 54: GLOBAL OTHER SUPPORTING EQUIPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - GLOBAL CELL EXPANSION MARKET BY APPLICATION

  • TABLE 55: GLOBAL CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • CLINICAL DIAGNOSTICS
    • CLINICAL TOXIC SHOCK SYNDROME DIAGNOSIS
    • CLINICAL HIV DIAGNOSIS
    • NEUROSPHERE (STEMNESS) ASSAYS
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 56: GLOBAL CLINICAL DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • DRUG DISCOVERY AND DEVELOPMENT
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 57: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • REGENERATIVE MEDICINE AND STEM CELL RESEARCH
    • TISSUE ENGINEERING AND ORGAN GRAFTING
    • DERMATOLOGICAL APPLICATIONS
    • CARDIOVASCULAR APPLICATIONS
    • CENTRAL NERVOUS SYSTEM (CNS) APPLICATIONS
    • ORTHOPEDIC APPLICATIONS
    • DENTAL APPLICATIONS
    • STEM CELL RESEARCH
      • Potential to Reverse Disease
      • Stem Cell Expansion Research
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 58: GLOBAL REGENERATIVE MEDICINE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHER APPLICATIONS
    • DISEASE MECHANISM STUDIES
    • PERSONALIZED MEDICINE
    • AUTOIMMUNE DISEASES
    • MUSCLE REGENERATION
    • OPHTHALMIC DISEASE
    • INTERNAL ORGAN REGENERATION
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 59: GLOBAL OTHER APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - GLOBAL CELL EXPANSION MARKET BY END USERS

  • MARKET SIZE AND FORECAST BY END USERS
    • TABLE 60: GLOBAL CELL EXPANSION MARKET BY END USERS, THROUGH 2020 ($ MILLIONS)
  • HOSPITALS AND DIAGNOSTIC CENTERS
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 61: GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • RESEARCH AND ACADEMIC INSTITUTES
    • KEY AREAS OF RESEARCH CARRIED OUT IN RESEARCH INSTITUTES
      • Organ or Tissue Development and Disease
      • Regenerative Therapies
      • Human Embryonic Stem Cells for Tissue Regeneration
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 62: GLOBAL RESEARCH AND ACADEMIC INSTITUTES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • BIO-PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • BIO-PHARMACEUTICAL COMPANIES
    • BIOTECHNOLOGY COMPANIES
    • MARKET SIZE AND FORECAST BY REGION
      • TABLE 63: GLOBAL BIO-PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - GLOBAL CELL EXPANSION MARKET BY REGION

  • NORTH AMERICA
    • MARKET SIZE AND FORECAST BY APPLICATION
      • TABLE 64: NORTH AMERICAN CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • MARKET SIZE AND FORECAST BY APPLICATION
      • TABLE 65: EUROPEAN CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • ASIA-PACIFIC
    • MARKET SIZE AND FORECAST BY APPLICATION
      • TABLE 66: ASIA-PACIFIC CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • ROW
    • MARKET SIZE AND FORECAST BY APLLICATION
      • TABLE 67: ROW CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

CHAPTER 9 - PATENT ANALYSIS

  • FIGURE 2: PERCENTAGE OF PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN, 2011-2015 (%)
  • U.S. PATENT ANALYSIS BY COMPANY
    • FIGURE 3: PERCENTAGE OF U.S. PATENTS REGISTERED BY COMPANY, 2011-2015 (%)
  • EUROPEAN PATENT ANALYSIS BY COMPANY
    • FIGURE 4: PERCENTAGE OF EUROPEAN PATENTS REGISTERED BY COMPANY, 2011-2015 (%)
  • JAPANESE PATENT ANALYSIS BY COMPANY
    • FIGURE 5: PERCENTAGE OF JAPANESE PATENTS REGISTERED BY COMPANY, 2011-2015 (%)

CHAPTER 10 - COMPETITIVE LANDSCAPE

  • FIGURE 6: COMPETITIVE STRATEGIES AND PERCENTAGE SHARE, 2011-2015 (%)
  • PRODUCT LAUNCH
    • FIGURE 7: PRODUCT LAUNCH STRATEGIES AND SHARE BY COMPANY, 2011-2015 (%)
    • TABLE 68: PRODUCT LAUNCH BY COMPANY, 2011-2015
  • AGREEMENT
    • FIGURE 8: AGREEMENT STRATEGY AND SHARE BY COMPANY, 2011-2015 (%)
    • TABLE 69: AGREEMENTS BY COMPANY, 2011-2015
  • APPROVAL
    • FIGURE 9: APPROVAL STRATEGY AND SHARE BY COMPANY, 2011-2015 (%)
    • TABLE 70: APPROVALS, 2011-2015

CHAPTER 11 - COMPANY PROFILES

  • BECTON, DICKINSON AND COMPANY
    • BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
      • TABLE 71: BECTON, DICKINSON AND COMPANY RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 72: BECTON, DICKINSON AND COMPANY FINANCIALS, 2013-2014
  • CELLPROTHERA
    • CELLPROTHERA PRODUCT PORTFOLIO
      • TABLE 73: CELLPROTHERA RECENT DEVELOPMENTS, 2011-APRIL 2015
  • CORNING INC.
    • CORNING INC. PRODUCT PORTFOLIO
      • TABLE 74: CORNING INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 75: CORNING INC. FINANCIALS, 2012-2014
  • CYTOMATRIX
    • CYTOMATRIX PRODUCT PORTFOLIO
      • TABLE 76: CYTOMATRIX RECENT DEVELOPMENTS, 2011-APRIL 2015
  • DANAHER CORP.
    • DANAHER CORP. PRODUCT PORTFOLIO
      • TABLE 77: DANAHER CORP. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 78: DANAHER CORP. FINANCIALS, 2011-2013
  • GE HEALTHCARE
    • GE HEALTHCARE PRODUCT PORTFOLIO
      • TABLE 79: GE HEALTHCARE RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 80: GE HEALTHCARE FINANCIALS, 2011-2013
  • LIFE TECHNOLOGIES LTD.
    • LIFE TECHNOLOGIES LTD. PRODUCT PORTFOLIO
      • TABLE 81: LIFE TECHNOLOGIES LTD. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 82: LIFE TECHNOLOGIES LTD. FINANCIALS, 2011-2012
  • MERCK MILLIPORE
    • MERCK MILLIPORE PRODUCT PORTFOLIO
      • TABLE 83: MERCK MILLIPORE RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 84: MERCK MILLIPORE FINANCIALS, 2012
  • MILTENYI BIOTEC
    • MILTENYI BIOTEC PRODUCT PORTFOLIO
      • TABLE 85: MILTENYI BIOTEC RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 86: MILTENYI BIOTEC FINANCIALS, 2013
  • NEXIMMUNE INC.
    • NEXIMMUNE INC. PRODUCT PORTFOLIO
      • TABLE 87: NEXIMMUNE INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
  • PLURISTEM THERAPEUTICS INC.
    • PLURISTEM THERAPEUTICS INC. PRODUCT PORTFOLIO
      • TABLE 88: PLURISTEM THERAPEUTICS INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 89: PLURISTEM THERAPEUTICS INC. FINANCIALS, 2012-2014
  • RENEURON GROUP PLC
    • RENEURON GROUP PLC PRODUCT PORTFOLIO
      • TABLE 90: RENEURON GROUP PLC RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 91: RENEURON GROUP PLC FINANCIALS, 2012-2013
  • REPLICEL LIFE SCIENCES INC.
    • REPLICEL LIFE SCIENCES INC. PRODUCT PORTFOLIO
      • TABLE 92: REPLICEL LIFE SCIENCES INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 93: REPLICEL LIFE SCIENCES INC. FINANCIALS, 2013
  • SIGMA-ALDRICH CORP.
    • SIGMA-ALDRICH PRODUCT PORTFOLIO
      • TABLE 94: SIGMA-ALDRICH CORP. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 95: SIGMA-ALDRICH FINANCIALS, 2012-2014
  • STEMCELL TECHNOLOGIES INC.
    • STEMCELL TECHNOLOGIES INC. PRODUCT PORTFOLIO
      • TABLE 96: STEMCELL TECHNOLOGIES INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
  • TC BIOPHARM LTD.
    • TC BIOPHARM LTD. PRODUCT PORTFOLIO
      • TABLE 97: TC BIOPHARM LTD. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 98: TC BIOPHARM LTD. FINANCIALS, 2014
  • TERUMO BCT
    • TERUMO BCT PRODUCT PORTFOLIO
      • TABLE 99: TERUMO BCT RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 100: TERUMO BCT FINANCIALS, 2012-2013
  • THERMO FISHER SCIENTIFIC INC.
    • THERMO FISHER SCIENTIFIC INC. PRODUCT PORTFOLIO
      • TABLE 101: THERMO FISHER SCIENTIFIC INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
      • TABLE 102: THERMO FISHER SCIENTIFIC FINANCIALS, 2011-2012
  • VORNIA BIOMATERIALS LTD.
    • VORNIA BIOMATERIALS LTD. PRODUCT PORTFOLIO

CHAPTER 12 - APPENDIX

  • TABLE 103: LIST OF U.S. PATENTS BY ASSIGNEE, 2011-APRIL 2015
  • TABLE 104: LIST OF EUROPEAN PATENTS BY ASSIGNEE, 2011-APRIL 2015
  • TABLE 105: LIST OF JAPANESE PATENTS BY ASSIGNEE, 2011-APRIL 2015

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: GUIDELINES ADOPTED FOR SUCCESSFUL CRYOPRESERVATION DURING CELL EXPANSION OPERATIONS
    • TABLE 2: CLINICAL TRIALS OF CELL EXPANSION RESEARCH (COMPLETED)
    • TABLE 3: CLINICAL TRIALS OF CELL EXPANSION RESEARCH (TERMINATED)
    • TABLE 4: OTHER CLINICAL TRIALS OF CELL EXPANSION RESEARCH
    • TABLE 5: CLINICAL TRIAL FOR INITIAL EVALUATION OF CELADERM ACTIVITY (COMPLETED)
    • TABLE 6: CLINICAL TRIAL FOR REGENERATIVE MEDICINE IN OCULAR SURFACE (COMPLETED)
    • TABLE 7: CLINICAL TRIAL FOR THE EFFECTS OF INTRA-ARTICULAR INJECTION OF PLATELET-RICH PLASMA
    • TABLE 8: CLONING SCENARIO IN ASIA-PACIFIC
    • TABLE 9: GLOBAL CELL EXPANSION MARKET BY CELL TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL ANIMAL CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: COMMONLY USED MATERIALS IN HUMAN CELL EXPANSION EXPERIMENTS BY COMPANY
    • TABLE 12: GLOBAL HUMAN CELL EXPANSION MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL HUMAN CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL HUMAN STEM CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL HUMAN DIFFERENTIATED CELL EXPANSION MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL CELL EXPANSION MARKET BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: GLOBAL CELL EXPANSION MARKET FOR CONSUMABLES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: GLOBAL CELL EXPANSION MARKET FOR COSUMABLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: SOME COMMERCIALLY AVAILABLE REAGENTS, MEDIA AND SERA
    • TABLE 20: GLOBAL REAGENTS, MEDIA AND SERA MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: GLOBAL DISPOSABLES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL DISPOSABLES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: SOME COMMERCIALLY AVAILABLE TISSUE CULTURE FLASKS
    • TABLE 24: GLOBAL CELL TISSUE CULTURE FLASKS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: COMMERCIALLY AVAILABLE UNIVESSEL BIOREACTORS BY HEIGHT (MM)
    • TABLE 26: COMMERCIALLY AVAILABLE BIOREACTOR ACCESSORIES
    • TABLE 27: GLOBAL BIOREACTOR ACCESSORIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: GLOBAL OTHER DISPOSABLES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: GLOBAL INSTRUMENTS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: GLOBAL INSTRUMENTS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: COMMERCIALLY AVAILABLE AUTOMATED CELL EXPANSION SYSTEMS
    • TABLE 32: GLOBAL AUTOMATED CELL EXPANSION SYSTEMS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: SOME COMMERCIALLY AVAILABLE BIOREACTORS FOR CELL EXPANSION
    • TABLE 34: GLOBAL BIOREACTORS INSTRUMENTS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: GLOBAL BIOREACTORS INSTRUMENTS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GLOBAL MICRO CARRIER BATCH CULTURE BIOREACTORS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL MICRO CARRIER BATCH CULTURE BIOREACTORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MICRO CARRIER BASED ANCHORAGE-DEPENDENT BATCH CULTURE BIOREACTORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL SUSPENSION-BASED ANCHORAGE-INDEPENDENT BATCH CULTURE BIOREACTOR MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL PERFUSION/HOLLOW FIBER BIOREACTOR MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL SUPPORTING EQUIPMENT MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL SUPPORTING EQUIPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: COMMERCIALLY AVAILABLE CENTRIFUGES FOR CELL EXPANSION
    • TABLE 44: GLOBAL CENTRIFUGE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: COMMERCIALLY AVAILABLE FLOW CYTOMETERS FOR CELL EXPANSION
    • TABLE 46: GLOBAL FLOW CYTOMETERS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 47: COMMERCIALLY AVAILABLE FILTRATION SYSTEMS USED IN CELL EXPANSION EXPERIMENTS
    • TABLE 48: GLOBAL FILTRATION SYSTEMS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: COMMERCIALLY AVAILABLE MICROSCOPES FOR CELL EXPANSION EXPERIMENTS
    • TABLE 50: GLOBAL MICROSCOPES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: COMMERCIALLY AVAILABLE INCUBATORS FOR CELL EXPANSION EXPERIMENTS
    • TABLE 52: GLOBAL INCUBATORS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: GLOBAL LAMINAR AIR FLOW CABINET MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: GLOBAL OTHER SUPPORTING EQUIPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 55: GLOBAL CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 56: GLOBAL CLINICAL DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 57: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 58: GLOBAL REGENERATIVE MEDICINE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 59: GLOBAL OTHER APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 60: GLOBAL CELL EXPANSION MARKET BY END USERS, THROUGH 2020 ($ MILLIONS)
    • TABLE 61: GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 62: GLOBAL RESEARCH AND ACADEMIC INSTITUTES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 63: GLOBAL BIO-PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 64: NORTH AMERICAN CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 65: EUROPEAN CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 66: ASIA-PACIFIC CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 67: ROW CELL EXPANSION MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 68: PRODUCT LAUNCH BY COMPANY, 2011-2015
    • TABLE 69: AGREEMENTS BY COMPANY, 2011-2015
    • TABLE 70: APPROVALS, 2011-2015
    • TABLE 71: BECTON, DICKINSON AND COMPANY RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 72: BECTON, DICKINSON AND COMPANY FINANCIALS, 2013-2014
    • TABLE 73: CELLPROTHERA RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 74: CORNING INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 75: CORNING INC. FINANCIALS, 2012-2014
    • TABLE 76: CYTOMATRIX RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 77: DANAHER CORP. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 78: DANAHER CORP. FINANCIALS, 2011-2013
    • TABLE 79: GE HEALTHCARE RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 80: GE HEALTHCARE FINANCIALS, 2011-2013
    • TABLE 81: LIFE TECHNOLOGIES LTD. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 82: LIFE TECHNOLOGIES LTD. FINANCIALS, 2011-2012
    • TABLE 83: MERCK MILLIPORE RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 84: MERCK MILLIPORE FINANCIALS, 2012
    • TABLE 85: MILTENYI BIOTEC RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 86: MILTENYI BIOTEC FINANCIALS, 2013
    • TABLE 87: NEXIMMUNE INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 88: PLURISTEM THERAPEUTICS INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 89: PLURISTEM THERAPEUTICS INC. FINANCIALS, 2012-2014
    • TABLE 90: RENEURON GROUP PLC RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 91: RENEURON GROUP PLC FINANCIALS, 2012-2013
    • TABLE 92: REPLICEL LIFE SCIENCES INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 93: REPLICEL LIFE SCIENCES INC. FINANCIALS, 2013
    • TABLE 94: SIGMA-ALDRICH CORP. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 95: SIGMA-ALDRICH FINANCIALS, 2012-2014
    • TABLE 96: STEMCELL TECHNOLOGIES INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 97: TC BIOPHARM LTD. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 98: TC BIOPHARM LTD. FINANCIALS, 2014
    • TABLE 99: TERUMO BCT RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 100: TERUMO BCT FINANCIALS, 2012-2013
    • TABLE 101: THERMO FISHER SCIENTIFIC INC. RECENT DEVELOPMENTS, 2011-APRIL 2015
    • TABLE 102: THERMO FISHER SCIENTIFIC FINANCIALS, 2011-2012
    • TABLE 103: LIST OF U.S. PATENTS BY ASSIGNEE, 2011-APRIL 2015
    • TABLE 104: LIST OF EUROPEAN PATENTS BY ASSIGNEE, 2011-APRIL 2015
    • TABLE 105: LIST OF JAPANESE PATENTS BY ASSIGNEE, 2011-APRIL 2015

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL CELL EXPANSION MARKET BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: VALUE CHAIN ANALYSIS FOR CELL EXPANSION MARKET
    • FIGURE 2: PERCENTAGE OF PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN, 2011-2015 (%)
    • FIGURE 3: PERCENTAGE OF U.S. PATENTS REGISTERED BY COMPANY, 2011-2015 (%)
    • FIGURE 4: PERCENTAGE OF EUROPEAN PATENTS REGISTERED BY COMPANY, 2011-2015 (%)
    • FIGURE 5: PERCENTAGE OF JAPANESE PATENTS REGISTERED BY COMPANY, 2011-2015 (%)
    • FIGURE 6: COMPETITIVE STRATEGIES AND PERCENTAGE SHARE, 2011-2015 (%)
    • FIGURE 7: PRODUCT LAUNCH STRATEGIES AND SHARE BY COMPANY, 2011-2015 (%)
    • FIGURE 8: AGREEMENT STRATEGY AND SHARE BY COMPANY, 2011-2015 (%)
    • FIGURE 9: APPROVAL STRATEGY AND SHARE BY COMPANY, 2011-2015 (%)
Back to Top